HOB Financial Statements From 2010 to 2025

Stocks . China . 
Stock . HOB Biotech Group
688656 Stock   89.05  5.10  6.08%   
HOB Biotech financial statements provide useful quarterly and yearly information to potential HOB Biotech Group investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on HOB Biotech financial statements helps investors assess HOB Biotech's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting HOB Biotech's valuation are summarized below:
Gross Profit
254.2 M
Profit Margin
0.0879
Market Capitalization
5.6 B
Enterprise Value Revenue
14.0031
Revenue
401.3 M
We have found sixty-six available fundamental measures for HOB Biotech, which can be analyzed and compared to other ratios and to its peers in the sector. All investors should make sure to confirm all of HOB Biotech latest market performance against the performance between 2010 and 2025 to make sure the company can sustain itself for few more years.

HOB Biotech Total Revenue

271.27 Million

Check HOB Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HOB Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 40.2 M, Interest Expense of 1.9 M or Selling General Administrative of 127.5 M, as well as many indicators such as . HOB financial statements analysis is a perfect complement when working with HOB Biotech Valuation or Volatility modules.
  
This module can also supplement various HOB Biotech Technical models . Check out the analysis of HOB Biotech Correlation against competitors.

HOB Biotech Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.1 B1.1 B426.1 M
Slightly volatile
Short and Long Term Debt Total44.6 M75.2 M43.4 M
Slightly volatile
Other Current Liabilities3.4 M3.6 M25.5 M
Very volatile
Total Current Liabilities102.6 M156.1 M83.3 M
Slightly volatile
Total Stockholder Equity979 M932.3 M327.3 M
Slightly volatile
Property Plant And Equipment Net698.8 M665.5 M210.3 M
Slightly volatile
Retained Earnings195.8 M186.4 M66.1 M
Slightly volatile
Accounts Payable15.2 M27.5 M12 M
Slightly volatile
Cash138.9 M188 M88.4 M
Slightly volatile
Non Current Assets Total749.9 M714.2 M238.1 M
Slightly volatile
Non Currrent Assets Other16.5 M18.9 M18 M
Slightly volatile
Cash And Short Term Investments349 M332.4 M127.2 M
Slightly volatile
Common Stock Shares Outstanding57.6 M72.5 M51.3 M
Slightly volatile
Liabilities And Stockholders Equity1.1 B1.1 B425.1 M
Slightly volatile
Non Current Liabilities Total2.4 M2.5 M11.5 M
Slightly volatile
Inventory69.7 M127.9 M55.3 M
Slightly volatile
Other Current Assets820.3 K863.5 K7.6 M
Slightly volatile
Other Stockholder Equity703.5 M670 M222.1 M
Slightly volatile
Total Liabilities116.4 M159.3 M95.6 M
Slightly volatile
Total Current Assets263.7 M377.4 M179.7 M
Slightly volatile
Short Term Debt34.4 M64 M34.4 M
Slightly volatile
Intangible Assets8.4 M13.6 M5.4 M
Slightly volatile
Common Stock51.2 M72.5 M36.9 M
Slightly volatile
Long Term Debt16 M27.6 M11.9 M
Slightly volatile
Net Receivables35.5 M47.7 M26.5 M
Slightly volatile
Net Invested Capital648.2 M995.4 M399.2 M
Slightly volatile
Short and Long Term Debt44.2 M63 M44.6 M
Pretty Stable
Capital Stock62.4 M72.5 M52.8 M
Slightly volatile
Non Current Liabilities Other1.8 M2 M2.2 M
Slightly volatile
Net Working Capital241 M221.3 M127.5 M
Slightly volatile
Capital Lease Obligations882.3 K928.8 K6.8 M
Slightly volatile
Property Plant And Equipment Gross489 M803.3 M302.7 M
Slightly volatile
Short Term Investments163.3 M155.5 M40.6 M
Slightly volatile

HOB Biotech Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization40.2 M38.2 M16.5 M
Slightly volatile
Interest Expense1.9 M2.9 M1.8 M
Slightly volatile
Selling General Administrative127.5 M121.4 M30.5 M
Slightly volatile
Selling And Marketing Expenses56.7 M90.5 M48.4 M
Slightly volatile
Total Revenue271.3 M453.6 M210.5 M
Slightly volatile
Gross Profit179.6 M281.7 M137.9 M
Slightly volatile
Other Operating Expenses193.2 M319.3 M166.3 M
Slightly volatile
Operating Income59.4 M63.5 M36.4 M
Slightly volatile
EBIT56.7 M54.7 M34.7 M
Slightly volatile
Research Development32.2 M54.1 M28.8 M
Slightly volatile
EBITDA75.5 M92.9 M49.8 M
Slightly volatile
Cost Of Revenue91.7 M171.8 M72.5 M
Slightly volatile
Total Operating Expenses409.6 M390.1 M141.4 M
Slightly volatile
Income Before Tax57.3 M65.1 M35.3 M
Slightly volatile
Net Income49.7 M54.4 M30.7 M
Slightly volatile
Tax Provision7.2 M8.4 M9.3 M
Slightly volatile
Interest Income1 M1.9 M783.4 K
Slightly volatile
Net Income From Continuing Ops47.3 M42.6 M60 M
Slightly volatile
Reconciled Depreciation27.6 M45.4 M19.9 M
Slightly volatile

HOB Biotech Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow118.3 M176.3 M77.5 M
Slightly volatile
Other Cashflows From Financing Activities47.9 M50.4 M77 M
Pretty Stable
Depreciation47.7 M45.4 M17.1 M
Slightly volatile
Dividends Paid23.5 M23.9 M14.2 M
Slightly volatile
Capital Expenditures215 M204.7 M77.8 M
Slightly volatile
Total Cash From Operating Activities64.3 M118.1 M43 M
Slightly volatile
Net Income49.8 M55.1 M30.8 M
Slightly volatile
End Period Cash Flow138.8 M188 M88.4 M
Slightly volatile

About HOB Biotech Financial Statements

HOB Biotech stakeholders use historical fundamental indicators, such as HOB Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Although HOB Biotech investors may analyze each financial statement separately, they are all interrelated. For example, changes in HOB Biotech's assets and liabilities are reflected in the revenues and expenses on HOB Biotech's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in HOB Biotech Group. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue453.6 M271.3 M
Cost Of Revenue171.8 M91.7 M

Currently Active Assets on Macroaxis

BTCBitcoin
TRXTRON
BNBBinance Coin
ADACardano
XRPXRP

Other Information on Investing in HOB Stock

HOB Biotech financial ratios help investors to determine whether HOB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HOB with respect to the benefits of owning HOB Biotech security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY